Itvisma (Onasemnogene Abeparvovec-Brve) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Itvisma. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Onasemnogene abeparvovec.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Onasemnogene abeparvovec.
Level 2 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Abemaciclib is combined with Onasemnogene abeparvovec.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Onasemnogene abeparvovec.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Acalabrutinib is combined with Onasemnogene abeparvovec.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Onasemnogene abeparvovec.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Onasemnogene abeparvovec.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Onasemnogene abeparvovec.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Onasemnogene abeparvovec.
Level 2 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Onasemnogene abeparvovec.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Acetazolamide is combined with Onasemnogene abeparvovec.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Onasemnogene abeparvovec.
Itvisma (Onasemnogene Abeparvovec-Brve) has 833 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Itvisma (Onasemnogene Abeparvovec-Brve) has 1 major, 830 moderate, and 2 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Itvisma. Always confirm against the full prescribing information.